ORX:STO
Orexo AB
SEKÂ 1.37
arrow_downward
-1.58%(-0.022) 1D
Nov 6, 5:29:49 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
5 Best Dow Stocks to Buy for 2027
BigGo Finance
·
3 hours ago
Tech Valuations Fall Below Broader Market for First Time in Nine Years; S&P 500 Tech Sector Forward P/E Drops to 17x
Traders Union
·
9 hours ago
Hedge fund performance lags S&P 500 at end of October, Peter Berezin notes
TradingView
·
22 hours ago
H&S in a Falling Channel, Short Toward 7,000 for CAPITALCOM:SPX500 by Audacity618
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com